PUBLISHED DATE : Mar 2023 | Pages : 279
Fill out your details & get your free sample
The Insulin Pump Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
279 Pages
110 Tables
140 Charts
5 Regions
18 Countries
15 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 6 Billion |
| Market Size (2022) | USD 3.68 Billion |
| CAGR (2022-2028) | 8.46% |
| BASE YEAR | 2022 |
| FORECAST YEAR | 2023-2028 |
| SEGMENTS BY | Products, Disease, End-Users, and Geography |
| LARGEST REGIONAL MARKET | North America |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Insulet Corporation, Medtronic, and Tandem Diabetes Care |
The global insulin pump market size was valued at USD 3.68 billion in 2022 and is expected to reach USD 6.00 billion by 2028, growing at a CAGR of 8.46% during the forecast period. The factors that accelerate insulin pump adoption and drive the market growth are the continuously increasing prevalence of Type 1 diabetes. Millions of Type 1 diabetes patients population are using an insulin pump. In addition, the growing research and development in diabetes technologies accelerated the advancement in insulin pumps, leading to high insulin pump market growth.
The diabetes care sector is one of the leading segments in healthcare, undergoing multiple changes. One of the revolutionary technologies is the continuous subcutaneous insulin delivery system. The insulin pump market is changing the landscape of diabetes care and management. In addition, continuous technological advancement is delivering new opportunities in diabetes care, which is expected to account for a high adoption rate in the upcoming years. The products launched in the market address the needs of the type-1 diabetic population. The adoption rate of insulin pumps among the type II diabetic population is minimal. The existing products in the industry are not fulfilling the needs of type II diabetic population needs, so there is a minimal adoption rate, and the rate of adoption has remained constant over time, and it is reducing. However, the insulin pump market vendors are launching products specific to type II diabetic patients; this is expected to drive the demand in the future. The introduction of insulin pumps with glucose sensors and continuous monitoring offers unique access to predicting glucose levels.
Apart from that, the factors limiting the insulin pump industry's growth are the high cost. Moreover, available alternative methods are majorly hampering the use of insulin pumps.
Technological Advancements Are Revolutionizing the Insulin Delivery
The insulin pump market is constantly evolving with new features with technological advancements like the launch of smarter insulin pumps and more connected devices. Most industry players, such as Medtronic, Tandem Diabetes Care, Insulet Corporation, and others, are continuously evolving in technology advancement and new product deliveries in recent years.
The explosion in research and development and published studies about the closed-loop system with insulin pumps in diabetes management gives new insulin pump market growth opportunities. Several hybrid systems are expected to be commercialized in the future associated with insulin delivery. In addition to those already available in the market, various systems are expected to be launched. For instance, DBLG1 (Diabeloop, Grenoble, France) received the CE market in European countries for its application in the type 1 diabetes adult patient population. Products like insulin-only iLEt (Beta Bionics, the US) and Omnipod Horizon (Insulet, Billerica, the US) are under clinical trials and are expected to reach the industry in the future.
Increasing Diabetes Prevalence & Expenditure
Under the overall diabetes population, type 1 diabetes patients are highly dependent on the external support of insulin delivery. These major patient populations significantly propel the insulin pump market growth. In 2021, the estimated prevalence of diabetes among adults 20 - 79 years old increased more than three times, from an estimated 151 million (approximately 4.6% of the global population at the time of 2000) to around 537 million (10.5%) in 2021. Based on that, by 2030, around 643 million population expected to increase. And if the prevalence rate remains the same, it is expected to jump to around 783 million (12.2%) by 2045.
Government Initiatives for Diabetes Care Management
Rising government initiatives for diabetes care management highly drive insulin pump market growth. Responding to the increasing burden of diabetes worldwide delivers a high demand for care. It positively influenced government initiatives and funding from public and private entities to improve global, regional, and national diabetes health improvements. Based on that, several government and health authorities are making efforts for diabetes care access to comprehensive, equitable, affordable, quality care and medical and technology-based treatments.
Available Reimbursement Policies and Healthcare Insurance for Insulin Pump
The cost of an insulin pump and associated insulin solutions is comparatively higher than other insulin delivery solutions due to the advancement and additional features associated with the products. However, the available reimbursement policies and healthcare insurance coverage highly support the adoption of insulin pumps. In most countries, these policies favor patients who reduce the cost burden and accelerate the adoption of insulin pumps. These insurances cover the insulin pump and include the insulin pump consumables. This is one of the positive signs that is driving the insulin pump market at a faster rate.
INSIGHTS BY PRODUCT
The global insulin pump market by product is segmented into the pump and consumables segment, under which insulin pumps is the major category used in diabetes management and account for a significant 65.85% industry share. The insulin pump adoption for type 1 diabetes patients is constantly increasing, boosting segmental growth. With the increasing diabetes prevalence and a significant burden on health systems, there is an increasing demand for new technologies in diabetes care delivery.
The advancement in insulin pumps stands as a golden opportunity for diabetes patients as well as healthcare professionals. It not only gives better clinical outcomes in diabetes management but also increases the confidence of patients and medical professionals in self-medication in diabetes care. It reduces hospital visits and associated cost burden and gives freedom from injections and interventions that take time to heal and deliver care. Insulin pumps are now available worldwide with advanced features that bring several advantages. In addition, the technology advancement, shifting diabetes patients from alternative methods to pumps used for insulin delivery, and the available reimbursement policies are some other factors accelerating the segmental growth.
INSIGHTS BY DISEASE
The global insulin pump market by patients is segmented into Type 1 diabetes and Type 2 diabetes. Type 1 diabetes dominated the disease segment and was valued at USD 3.33 billion in 2022. In the type 1 diabetes patient population, an insulin pump plays a vital role, delivering better glycemic control than multiple daily injections. Children are the major targeted population that receives insulin through continuous subcutaneous insulin infusions such as insulin pumps. Also, in the pediatric type 1 diabetes population, insulin pumps showed better glycemic control, which induced a significant demand for insulin pumps. Further, Type 1 diabetes patients are highly dependent on external insulin delivery support due to the loss of insulin production ability. Most of the insulin-dependent type 1 diabetes patients in developed countries accepted the use of insulin pumps over the other alternative methods and contributed to higher market growth.
INSIGHTS BY END-USERS
The hospitals end-user accounted for 51.82% insulin pump market share and dominated the end-user segment. Hospitals are the major contributor to the adoption of insulin pumps. The significant patient population is dependent on hospital settings to manage their diabetes. As the prevalence of diabetes increases every day, the demand and popularity of diabetes management devices are increasing, and insulin pumps are becoming a top priority for medical professionals. The use of insulin pumps has shown tremendous medical outcomes with appropriate insulin delivery in Type 1 & Type 2 diabetes patients. People's quality of life is improving over the traditional and alternative methods. Such factors increase high insulin pump consumption in hospital settings and contribute to significant segmental growth.
North America dominates the global insulin pump market with the higher use of insulin pumps in various demographics suffering from diabetes. The substantial diabetes management burden and higher expenditure in the region accelerate the highest insulin pump adoption. One in three Type 1 diabetes patient population uses insulin pumps in the US only, accounting for more than 30% of Type 1 diabetes patients using insulin pumps in the country. In terms of research and development, advancement in insulin pumps, higher expenditure on diabetes care and management, and government initiatives are some factors that fuel the industry growth in the region.
The insulin pump market in Europe was valued at USD 1.17 billion in 2022. In Europe, domestic and international market players initiated innovative clinical research in insulin pump therapy when the adoption of insulin pumps was limited in the last decades. The increasing prevalence of Type 1 diabetes among European countries is the key factor fueling the acceptance of insulin pumps. Also, the increasing expenditure for diabetes management in Germany, France, the UK, Italy, Spain, and the Netherlands delivers lucrative market growth opportunities.
APAC is a rapidly growing insulin pump market with a significant volume of diabetes patient population and rising diabetes health expenditure. In Southeast Asia, around 90 million adults, and in the Western Pacific region, approximately 206 million diabetes patient population was accounted for in 2021. Further, in 2022, APAC accounted for a 20.90% market share in the global insulin pump market. China is one of the dominating countries for insulin pumps as the higher expenditure and highest diabetes patient population across the world. In addition, the available greater access and continuous development in insulin pump delivery devices increase awareness among the people.
The global insulin pump market is highly concentrated, with a limited number of players. Various innovative products like patch pumps are being introduced into the market, and the adoption rate is comparatively higher. Tandem Diabetes Care is one of the leading companies in the insulin pump market; estimated that around 750,000 people in the U.S. are currently using an insulin pump. Moreover, the company stated that approximately 450,000 people use insulin pumps in more than 20 countries outside the United States. The company’s insulin pump is widely available in the global market.
Insulet is one of the leading market players in the insulin pump market, accounting for a significant industry share. The company offers advanced and cutting-edge technologically improved insulin delivery system and stand as one of the leading companies in the market. In the US industry, only three companies commercialize insulin pumps to manage Type 1 & Type 2 diabetes patients. Medtronic is one of the leading companies in the U.S. insulin pump market, commercializing the durable insulin pump “MiniMed 770G and older durable insulin pumps such as MiniMed 630G and 670G.
Frequently Asked Questions
How big is the global insulin pump market?
The global insulin pump market size was valued at USD 3.68 billion in 2022 and is expected to reach USD 6 billion by 2028.
What is the growth rate of the insulin pump market?
The global insulin pump market size is growing at a CAGR of 8.46% from 2022-2028.
Who are the key players in the global insulin pump market?
Insulet Corporation, Medtronic, and Tandem Diabetes Care are the key players in the global insulin pump market.
What are the growing trends in the insulin pump market?
New products launched and technological advancement in diabetes care, increasing demand for closed-loop technology, and transition of patients from multiple daily injections to the insulin pump are key trends in the global insulin pump market.
Which region holds the most significant global insulin pump market share?
In the global insulin pump market, North America accounted for 38.81% of the highest market share and dominated other regions. In North America, a substantial diabetes patient population, constantly growing diabetes health expenditure, high awareness about insulin pumps, and broader vendor presence are some of the leading factors fueling the industry's growth.
The insulin pump market size is expected to grow at a CAGR of approximately 8.46% from 2022 to 2028.
The following factors are likely to contribute to the growth of the insulin pump market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the insulin pump market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation By Products
Segmentation By Disease
Segmentation By End-Users
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY PATIENT GROUP
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 NEW PRODUCT LAUNCHES AND TECHNOLOGICAL ADVANCES IN DIABETES CARE
9.2 INCREASE IN DEMAND FOR CLOSED-LOOP TECHNOLOGY
9.3 TRANSITION OF PATIENTS FROM MULTIPLE DAILY INJECTIONS TO INSULIN PUMPS
10 MARKET GROWTH ENABLERS
10.1 INCREASE IN PREVALENCE OF DIABETES & EXPENDITURE
10.2 GOVERNMENT INITIATIVES FOR DIABETES CARE MANAGEMENT
10.3 AVAILABLE REIMBURSEMENT POLICIES AND HEALTHCARE INSURANCE FOR INSULIN PUMPS
11 MARKET RESTRAINTS
11.1 HIGH-COST BURDEN OF INSULIN PUMPS
11.2 AVAILABLE ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
11.3 INCREASE IN UNDIAGNOSED DIABETIC POPULATION
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PATIENT GROUP
12.2.2 INSIGHTS BY PRODUCT
12.2.3 INSIGHTS BY END-USER
12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PUMP
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 TETHERED PUMP
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 PATCH PUMP
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 CONSUMABLES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
14 PATIENT GROUP
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 TYPE 1 DIABETES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 TYPE 2 DIABETES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 HOME HEALTHCARE SETTINGS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 OTHERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 PRODUCT
17.3.1 MARKET SIZE & FORECAST
17.4 PUMP
17.4.1 MARKET SIZE & FORECAST
17.5 PATIENT GROUP
17.5.1 MARKET SIZE & FORECAST
17.6 END-USER
17.6.1 MARKET SIZE & FORECAST
17.7 KEY COUNTRIES
17.7.1 US: MARKET SIZE & FORECAST
17.7.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT
18.3.1 MARKET SIZE & FORECAST
18.4 PUMP
18.4.1 MARKET SIZE & FORECAST
18.5 PATIENT GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 END-USER
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 FRANCE: MARKET SIZE & FORECAST
18.7.3 UK: MARKET SIZE & FORECAST
18.7.4 ITALY: MARKET SIZE & FORECAST
18.7.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT
19.3.1 MARKET SIZE & FORECAST
19.4 PUMP
19.4.1 MARKET SIZE & FORECAST
19.5 PATIENT GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 END-USER
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 CHINA: MARKET SIZE & FORECAST
19.7.2 JAPAN: MARKET SIZE & FORECAST
19.7.3 INDIA: MARKET SIZE & FORECAST
19.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.7.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT
20.3.1 MARKET SIZE & FORECAST
20.4 PUMP
20.4.1 MARKET SIZE & FORECAST
20.5 PATIENT GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 END-USER
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 BRAZIL: MARKET SIZE & FORECAST
20.7.2 MEXICO: MARKET SIZE & FORECAST
20.7.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT
21.3.1 MARKET SIZE & FORECAST
21.4 PUMP
21.4.1 MARKET SIZE & FORECAST
21.5 PATIENT GROUP
21.5.1 MARKET SIZE & FORECAST
21.6 END-USER
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 TURKEY: MARKET SIZE & FORECAST
21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 INSULET CORPORATION
22.2.2 MEDTRONIC
22.2.3 TANDEM DIABETES CARE
23 KEY COMPANY PROFILES
23.1 INSULET CORPORATION
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 MEDTRONIC
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 TANDEM DIABETES CARE
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 CEQUR SIMPLICITY
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 EOFLOW
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 DEBIOTECH SA
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 F-HOFFMANN-LA ROCHE
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 MEDZER.COM
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 MICROPORT SCIENTIFIC
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 NOVO NORDISK A/S
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 SOOIL DEVELOPMENTS CO., LTD.
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 TERUMO
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 VICENTRA B. V.
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 YPSOMED
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 MANNKIND
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY PRODUCT
26.3 MARKET BY PATIENT GROUP
26.4 MARKET BY END-USER
26.5 PRODUCT: MARKET BY GEOGRAPHY
26.5.1 PUMP: MARKET BY GEOGRAPHY
26.5.2 CONSUMABLES: MARKET BY GEOGRAPHY
26.5.3 TETHERED PUMP: MARKET BY GEOGRAPHY
26.5.4 PATCH PUMP: MARKET BY GEOGRAPHY
26.6 PATIENT GROUP: MARKET BY GEOGRAPHY
26.6.1 TYPE 1 DIABETES: MARKET BY GEOGRAPHY
26.6.2 TYPE 2 DIABETES: MARKET BY GEOGRAPHY
26.7 END-USER: MARKET BY GEOGRAPHY
26.7.1 HOSPITALS: MARKET BY GEOGRAPHY
26.7.2 HOME HEALTHCARE SETTINGS: MARKET BY GEOGRAPHY
26.7.3 OTHERS: MARKET BY GEOGRAPHY
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL INSULIN PUMPS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 GLOBAL INSULIN PUMPS MARKET: OPPORTUNITIES, DRIVERS, & RESTRAINTS
EXHIBIT 4 GLOBAL INSULIN PUMPS MARKET SEGMENTATION 2022–2028
EXHIBIT 5 GLOBAL INCIDENCE NUMBER AND INCIDENCE RATE OF DIABETES 1990–2025
EXHIBIT 6 GLOBAL PREVALENCE AND PREVALENCE RATE OF DIABETES 1990–2025
EXHIBIT 7 GLOBAL DIABETES ASSOCIATED DEATH AND MORTALITY RATE 1990-2025
EXHIBIT 8 GLOBAL DALYS NUMBER AND DALYS RATE OF DIABETES 1990–2025
EXHIBIT 9 GLOBAL DIABETES PREVALENCE & ASSOCIATED TARGET PATIENT POPULATION IN 2021 (MILLION)
EXHIBIT 10 IMPACT OF NEW PRODUCT LAUNCHES AND TECHNOLOGICAL ADVANCES IN DIABETES CARE
EXHIBIT 11 IMPACT OF INCREASE IN DEMAND FOR CLOSED-LOOP TECHNOLOGY
EXHIBIT 12 EVOLUTION OF INSULIN PUMP TECHNOLOGY
EXHIBIT 13 IMPACT OF TRANSITION OF PATIENTS FROM MULTIPLE DAILY INJECTIONS TO INSULIN PUMPS
EXHIBIT 14 SHIFT FROM MDI TO INSULIN PUMPS: BASED ON VENDOR ANALYSIS 2021
EXHIBIT 15 IMPACT OF INCREASE IN PREVALENCE OF DIABETES & EXPENDITURE
EXHIBIT 16 PEOPLE WITH DIABETES WORLDWIDE & BY IDF REGION 2021–2045 (20–79 YEARS) (MILLION)
EXHIBIT 17 IMPACT OF GOVERNMENT INITIATIVES FOR DIABETES CARE MANAGEMENT
EXHIBIT 18 IMPACT OF AVAILABLE REIMBURSEMENT POLICIES AND HEALTHCARE INSURANCE FOR INSULIN PUMPS
EXHIBIT 19 REIMBURSEMENT STRUCTURE FOR INSULIN PUMPS
EXHIBIT 20 IMPACT OF HIGH-COST BURDEN OF INSULIN PUMPS
EXHIBIT 21 IMPACT OF AVAILABLE ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
EXHIBIT 22 IMPACT OF ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
EXHIBIT 23 IMPACT OF INCREASE IN UNDIAGNOSED DIABETIC POPULATION
EXHIBIT 24 PREVALENCE OF UNDIAGNOSED DIABETIC POPULATION IN KEY COUNTRIES 2020
EXHIBIT 25 UNDIAGNOSED POPULATION WITH DIABETES BY ECONOMY IN 2020 (MILLIONS)
EXHIBIT 26 GLOBAL INSULIN PUMPS MARKET 2022–2028 ($ MILLION)
EXHIBIT 27 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP
EXHIBIT 28 GLOBAL INSULIN PUMPS MARKET BY PRODUCT
EXHIBIT 29 GLOBAL INSULIN PUMPS MARKET BY END-USER
EXHIBIT 30 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY
EXHIBIT 31 FIVE FORCES ANALYSIS 2022
EXHIBIT 32 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 33 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022-2028
EXHIBIT 34 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY PRODUCT
EXHIBIT 35 GLOBAL INSULIN PUMPS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 36 GLOBAL INSULIN PUMPS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL INSULIN PUMPS MARKET BY PUMP SEGMENT: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL INSULIN PUMPS MARKET BY PUMP SEGMENT 2022–2028 ($ MILLION)
EXHIBIT 39 GLOBAL INSULIN PUMPS MARKET BY TETHERED PUMP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL INSULIN PUMPS MARKET BY TETHERED PUMP 2022–2028 ($ MILLION)
EXHIBIT 41 GLOBAL INSULIN PUMPS MARKET BY PATCH PUMP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL INSULIN PUMPS MARKET BY PATCH PUMP 2022–2028 ($ MILLION)
EXHIBIT 43 GLOBAL INSULIN PUMPS MARKET BY CONSUMABLES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL INSULIN PUMPS MARKET BY CONSUMABLES 2022–2028 ($ MILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY PATIENT GROUP 2022 & 2028
EXHIBIT 46 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2029
EXHIBIT 47 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP
EXHIBIT 48 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP: INCREMENTAL GROWTH
EXHIBIT 49 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP: ABSOLUTE GROWTH
EXHIBIT 50 TYPE 1 DIABETES PREVALENCE IN AGE GROUP 0–19 IN 2021
EXHIBIT 51 GLOBAL INSULIN PUMPS MARKET BY TYPE 1 DIABETES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL INSULIN PUMPS MARKET BY TYPE 1 DIABETES 2022–2028 ($ MILLION)
EXHIBIT 53 GLOBAL INSULIN PUMPS MARKET BY TYPE 2 DIABETES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL INSULIN PUMPS MARKET BY TYPE 2 DIABETES 2022–2028 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 56 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022-2028
EXHIBIT 57 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY END-USER
EXHIBIT 58 GLOBAL INSULIN PUMPS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 59 GLOBAL INSULIN PUMPS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL INSULIN PUMPS MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL INSULIN PUMPS MARKET BY HOSPITALS 2022–2028 ($ MILLION)
EXHIBIT 62 PREVALENCE OF CHRONIC CONDITIONS AND EXPONENTIAL IMPACT ON HEALTHCARE COSTS IN US
EXHIBIT 63 GLOBAL INSULIN PUMPS MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL INSULIN PUMPS MARKET BY HOME HEALTHCARE SETTINGS 2022–2028 ($ MILLION)
EXHIBIT 65 GLOBAL INSULIN PUMPS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL INSULIN PUMPS MARKET BY OTHERS 2022–2028 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 68 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028
EXHIBIT 69 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY
EXHIBIT 70 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 71 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 72 NORTH AMERICA DIABETES STATISTICS 2021
EXHIBIT 73 INSULIN PUMPS MARKET IN NORTH AMERICA: KEY COUNTRIES ($ MILLION)
EXHIBIT 74 INSULIN PUMPS MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 INSULIN PUMPS MARKET IN NORTH AMERICA 2022–2028 ($ MILLION)
EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 77 US TYPE 1 DIABETES STATISTICS (ESTIMATION & PROJECTED POPULATION STATISTICS, 2020–2021 & 2021–2050)
EXHIBIT 78 TYPE 1 DIABETES POPULATION USED INSULIN PUMPS IN US IN 2018 (% SHARE)
EXHIBIT 79 ADOPTION OF INSULIN PUMPS IN US 2020-2022
EXHIBIT 80 INSULIN PUMPS MARKET IN US 2022–2028 ($ MILLION)
EXHIBIT 81 TYPE 1 DIABETES STATISTICS OF CANADA 2021
EXHIBIT 82 INSULIN PUMPS MARKET IN CANADA 2022–2028 ($ MILLION)
EXHIBIT 83 INSULIN PUMPS MARKET IN EUROPE: KEY COUNTRIES ($ MILLION)
EXHIBIT 84 INSULIN PUMPS MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 85 INSULIN PUMPS MARKET IN EUROPE 2022–2028 ($ MILLION)
EXHIBIT 86 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 87 ESTIMATED & PREDICTED DIABETES MANAGEMENT EXPENDITURE IN GERMANY 2021, 2030, & 2045 ($ BILLION)
EXHIBIT 88 INSULIN PUMPS MARKET IN GERMANY 2022–2028 ($ MILLION)
EXHIBIT 89 FRANCE DIABETES STATISTICS 2021
EXHIBIT 90 INSULIN PUMPS MARKET IN FRANCE 2022–2028 ($ MILLION)
EXHIBIT 91 UK TYPE 1 DIABETES PREVALENCE STATISTICS & INSULIN PUMP ACCEPTANCE (2016–2021)
EXHIBIT 92 INSULIN PUMPS MARKET IN UK 2022–2028 ($ MILLION)
EXHIBIT 93 ACCESS TO DIABETES CARE & DELIVERY CYCLE FOR SUPPLIES & TECHNOLOGIES IN ITALY
EXHIBIT 94 INSULIN PUMPS MARKET IN ITALY 2022–2028 ($ MILLION)
EXHIBIT 95 INSULIN PUMPS MARKET IN SPAIN 2022–2028 ($ MILLION)
EXHIBIT 96 ESTIMATED & PROJECTED DIABETES PREVALENCE IN APAC 2021–2045 (MILLION)
EXHIBIT 97 INSULIN PUMPS MARKET IN APAC: KEY COUNTRIES ($ MILLION)
EXHIBIT 98 INSULIN PUMPS MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 99 INSULIN PUMPS MARKET IN APAC 2022–2028 ($ MILLION)
EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 101 DIABETES-RELATED ESTIMATED AND PREDICTED HEALTH EXPENDITURE OF CHINA 2021, 2030, & 2045 ($ BILLION)
EXHIBIT 102 INSULIN PUMPS MARKET IN CHINA 2022–2028 ($ MILLION)
EXHIBIT 103 INSULIN PUMPS MARKET IN JAPAN 2022–2028 ($ MILLION)
EXHIBIT 104 DIABETES-RELATED HEALTH EXPENDITURE ESTIMATION & PREDICTION FROM 2021 TO 2045 ($ MILLION)
EXHIBIT 105 INDIA DIABETES STATISTICS 2021–2045
EXHIBIT 106 INSULIN PUMPS MARKET IN INDIA 2022–2028 ($ MILLION)
EXHIBIT 107 DIABETES PREVALENCE &ASSOCIATED EXPENDITURE 2021–2045
EXHIBIT 108 INSULIN PUMPS MARKET IN SOUTH KOREA 2022–2028 ($ MILLION)
EXHIBIT 109 PREVALENCE OF DIABETES IN AUSTRALIA 2021
EXHIBIT 110 INSULIN PUMPS MARKET IN AUSTRALIA 2022–2028 ($ MILLION)
EXHIBIT 111 INSULIN PUMPS MARKET IN LATIN AMERICA: KEY COUNTRIES ($ MILLION)
EXHIBIT 112 INSULIN PUMPS MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 113 INSULIN PUMPS MARKET IN LATIN AMERICA 2022–2028 ($ MILLION)
EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 115 INSULIN PUMPS MARKET IN BRAZIL 2022–2028 ($ MILLION)
EXHIBIT 116 ESTIMATED & PROJECTED DIABETES PREVALENCE IN MEXICO 2021, 2030, & 2045 (MILLION)
EXHIBIT 117 DIABETES-RELATED ESTIMATED & PROJECTED EXPENDITURE IN MEXICO 2021, 2030, & 2045 ($ BILLION)
EXHIBIT 118 INSULIN PUMPS MARKET IN MEXICO 2022–2028 ($ MILLION)
EXHIBIT 119 DIABETES-RELATED HEALTH EXPENDITURE IN ARGENTINA 2021, 2030, & 2045 ($ BILLION)
EXHIBIT 120 INSULIN PUMPS MARKET IN ARGENTINA 2022–2028 ($ MILLION)
EXHIBIT 121 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 122 PREVALENCE OF DIABETES IN MIDDLE EAST & AFRICA 2021–2045 (MILLION)
EXHIBIT 123 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES ($ MILLION)
EXHIBIT 124 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA 2022–2028 ($ MILLION)
EXHIBIT 125 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 126 DIABETES PREVALENCE IN TURKEY AMONG ADULTS OF AGE 20–79 YEARS (MILLION)
EXHIBIT 127 DIABETES-RELATED HEALTH EXPENDITURE IN TURKEY 2021, 2030, & 2045 ($ BILLION)
EXHIBIT 128 INSULIN PUMPS MARKET IN TURKEY 2022–2028 ($ MILLION)
EXHIBIT 129 ESTIMATED AND PROJECTED DIABETES PREVALENCE IN SAUDI ARABIA 2000–2045 (MILLION)
EXHIBIT 130 INSULIN PUMPS MARKET IN SAUDI ARABIA 2022–2028 ($ MILLION)
EXHIBIT 131 ESTIMATED AND PROJECTED DIABETES PREVALENCE IN SOUTH AFRICA 2000–2045 (MILLION)
EXHIBIT 132 DIABETES-RELATED ESTIMATED & PROJECTED HEALTH EXPENDITURE IN SOUTH AFRICA 2021–2045 ($ MILLION)
EXHIBIT 133 INSULIN PUMPS MARKET IN SOUTH AFRICA 2022–2028 ($ MILLION)
EXHIBIT 134 KEY VENDORS OFFERING INSULIN PUMPS: MARKET DOMINANCE ANALYSIS
EXHIBIT 135 KEY VENDORS OFFERING INSULIN PUMPS: CAPABILITIES & EXPERTISE ASSESSMENTS
EXHIBIT 136 ANNUAL REVENUE OF INSULET CORPORATION 2019–2021 ($ MILLION)
EXHIBIT 137 INSULET CORPORATION: REVENUE OF DIABETES SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 138 MEDTRONIC REVENUE 2019–2021 ($ BILLION)
EXHIBIT 139 TANDEM DIABETES CARE REVENUE 2019–2021 ($ MILLION)
EXHIBIT 140 TANDEM DIABETES CARE REVENUE 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 DIABETES PREVALENCE BY WORLD BANK INCOME CLASSIFICATION (ESTIMATION AND PREDICTION) 2021–2045
TABLE 4 ADULTS (20–79 YEARS) WITH UNDIAGNOSED DIABETES BY WORLD BANK INCOME CLASSIFICATION IN 2021
TABLE 5 PRESENCE OF LARGE POOL OF UNDIAGNOSED POPULATION
TABLE 6 PRICING OF INSULIN PUMPS
TABLE 7 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 8 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 9 GLOBAL TETHERED INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 10 GLOBAL TETHERED INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 11 SOME PATCH PUMPS BY MARKET PLAYERS
TABLE 12 GLOBAL PATCH INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 13 GLOBAL PATCH INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 14 GLOBAL INSULIN PUMPS CONSUMABLES MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 15 GLOBAL INSULIN PUMPS CONSUMABLES MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 16 TYPE OF DIABETES & ASSOCIATED MARKET OPPORTUNITIES
TABLE 17 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 18 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 19 INSULIN PUMPS DESIGNED SPECIFICALLY FOR TYPE 2 DIABETIC PATIENTS
TABLE 20 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 21 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 22 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 23 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 24 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 25 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 26 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 27 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 28 NORTH AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 29 NORTH AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 30 NORTH AMERICA INSULIN PUMPS MARKET BY PUMP 2022–2028 ($ MILLION)
TABLE 31 NORTH AMERICA INSULIN PUMPS MARKET BY PUMP 2022–2028 (%)
TABLE 32 NORTH AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 33 NORTH AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 34 NORTH AMERICA INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 35 NORTH AMERICA INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 36 EUROPE INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 37 EUROPE INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 38 EUROPE INSULIN PUMPS MARKET BY PUMP 2022–2028 ($ MILLION)
TABLE 39 EUROPE INSULIN PUMPS MARKET BY PUMP 2022–2028 (%)
TABLE 40 EUROPE INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 41 EUROPE INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 42 EUROPE INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 43 EUROPE INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 44 DIABETES-RELATED HEALTH EXPENDITURE 2021–2045 ($ MILLION)
TABLE 45 APAC INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 46 APAC INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 47 APAC INSULIN PUMPS MARKET BY PUMP 2022–2028 ($ MILLION)
TABLE 48 APAC INSULIN PUMPS MARKET BY PUMP 2022–2028 (%)
TABLE 49 APAC INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 50 APAC INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 51 APAC INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 52 APAC INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 53 DIABETIC PATIENT POPULATION STATISTICS IN CHINA
TABLE 54 LATIN AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 55 LATIN AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 56 LATIN AMERICA INSULIN PUMPS MARKET BY PUMP 2022–2028 ($ MILLION)
TABLE 57 LATIN AMERICA INSULIN PUMPS MARKET BY PUMP 2022–2028 (%)
TABLE 58 LATIN AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 59 LATIN AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 60 LATIN AMERICA INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 61 LATIN AMERICA INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 62 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 63 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 64 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PUMP 2022–2028 ($ MILLION)
TABLE 65 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PUMP 2022–2028 (%)
TABLE 66 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 67 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 68 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 69 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 70 INSULET CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 71 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 72 TANDEM DIABETES CARE: MAJOR PRODUCT OFFERINGS
TABLE 73 CEQUR SIMPLICITY: MAJOR PRODUCT OFFERINGS
TABLE 74 EOFLOW: MAJOR PRODUCT OFFERINGS
TABLE 75 DEBIOTECH SA: MAJOR PRODUCT OFFERINGS
TABLE 76 F-HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 77 MEDZER.COM: MAJOR PRODUCT OFFERINGS
TABLE 78 MICROPORT SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 79 NOVO NORDISK A/S: MAJOR PRODUCT OFFERINGS
TABLE 80 SOOIL DEVELOPMENTS CO., LTD.: MAJOR PRODUCT OFFERINGS
TABLE 81 TERUMO: MAJOR PRODUCT OFFERINGS
TABLE 82 VICENTRA B.V.: MAJOR PRODUCT OFFERINGS
TABLE 83 YPSOMED: MAJOR PRODUCT OFFERINGS
TABLE 84 MANNKIND: MAJOR PRODUCT OFFERINGS
TABLE 85 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 86 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 87 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022–2028 ($ MILLION)
TABLE 88 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022–2028 (%)
TABLE 89 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 ($ MILLION)
TABLE 90 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 91 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 92 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022–2028 (%)
TABLE 93 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 94 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 95 GLOBAL CONSUMABLES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 96 GLOBAL CONSUMABLES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 97 GLOBAL TETHERED INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 98 GLOBAL TETHERED INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 99 GLOBAL PATCH INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 100 GLOBAL PATCH INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 101 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 102 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 103 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 104 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 105 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 106 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 107 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 108 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 109 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 110 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
